[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_899 

# __Cost savings in healthcare__

## Articles mentionning this Benefit

* [Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_182.md)

## Stakeholders benefitting from this Benefit

* [healthcare institutions](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_269.md)
* [insurance companies](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_358.md)

## Description of Benefits pertaining to Beneficiaries

* [Healthcare institutions and insurance companies would benefit from reduced expenses associated with treating and managing infectious diseases caused by person-to-person transmission.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_985.md)

## Name of the Benefit

The use of far-UVC light in public places can reduce the spread of infectious diseases, resulting in fewer cases and lower healthcare costs.

